I don't think that's the likely outcome, as the FDA cares little for European standards.
What it does mean is that the CE mark will be harder to get, so marketing new products into Europe will be harder. Thus the CE mark will be a more valuable asset, and provide a bigger moat against competitors.
- Forums
- ASX - By Stock
- OSL
- Ann: CE Mark Update
Ann: CE Mark Update, page-286
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.2¢ |
Change
-0.001(4.17%) |
Mkt cap ! $45.40M |
Open | High | Low | Value | Volume |
1.2¢ | 1.2¢ | 1.2¢ | $3.318K | 277.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 4850000 | 1.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.2¢ | 4285138 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 4850000 | 0.011 |
30 | 14880610 | 0.010 |
17 | 9703444 | 0.009 |
9 | 5477500 | 0.008 |
8 | 3764285 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 4285138 | 10 |
0.013 | 11473998 | 7 |
0.014 | 6014139 | 9 |
0.015 | 8500000 | 3 |
0.016 | 4766668 | 3 |
Last trade - 11.01am 04/09/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |